This really is a 'steal' at current prices. Now that it is clear just how excited Amicus is - at having gained what they perceive as cheap access to DMX200 which they see as a 'blockbuster' oportunity - and knowing that they have based their commitment on having access to the blinded data in both the phase 2 and 3 trials, an investment here us a clear no brainer!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $305.9M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 53.5¢ | 50.0¢ | $745.8K | 1.461M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2571 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.5¢ | 44841 | 11 |
View Market Depth
| Last trade - 14.35pm 17/06/2025 (20 minute delay) ? |
| DXB (ASX) Chart |